Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX- 38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen

Transplantation

Volumn 63, Issue 2, 1997, Pages 284-292

  Arima, Takeshi ^b   Lehmann, Manfred ^b   Flye, M Wayne ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 2;

ALLOGRAFT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; THYMUS; TREATMENT OUTCOME;

EID: 0030970045     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701270-00019     Document Type: Article

References (64)

1. Reinherz EL, Schlossman SF. The differentiation and function of human T lymphocytes. Cell 1980; 19: 821.
2. Zuniga-Pflucker JC, McCarthy SA, Weston M, Longo DL, Singer A, Kruisbeek AM. Role of CD4 in thymocyte selection and maturation. J Exp Med 1989; 169: 2085.
3. Teh HS, Garvin AM, Forbush KA, et al. Participation of CD4 coreceptor molecules in T-cell repertoire selection. Nature 1991; 349: 241.
4. Swain SL. T cell subsets and the recognition of MHC class. Immunol Rev 1983; 74: 129.
5. Loveland BE, Hogarth PM, Ceredig R, McKenzie IF. Cells mediating graft rejection in the mouse: I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044.
6. Dallman MJ, Mason DW, Webb M. The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells. Eur J Immunol 1982; 12: 511.
7. Mason DW, Morris PJ. Effector mechanisms in allograft rejection. Annu Rev Immunol 1986; 4: 119.
8. Cobbold S, Waldmann H. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets (erratum: Transplantation 1986; 42: 332). Transplantation 1986; 41: 634.
9. Wheelahan J, McKenzie IF. The role of T4+ and Lyt-2+ cells in skin graft rejection in the mouse. Transplantation 1987; 44: 273.
10. Madsen JC, Peugh IN, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44: 849.
11. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988; 46: 128.
12. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
13. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
14. + T cells and inversion of the CD4/ CD8 T cell ratio induced by anti-CD4 therapy. J Rheumatol 1992; 19: 1845.
15. van der Lubbe PA, Reiter C, Breedveld FC, et al. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthritis Rheum 1993; 36: 1375.
16. Tak PP, van der Lubbe PA, Cauli A, et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995; 38: 1457.
17. Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody: long-term followup of CD4+ T cell counts. Arthritis Rheum 1994; 37: 834.
18. Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy: a protocol with significant clinical potential. Transplantation 1994; 58: 133.
19. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
20. Arima T, Goss JA, Walp LA, Flye MW. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance. Surgery 1995; 118: 265.
21. Lehmann M, Sternkopf F, Metz F, et al. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992; 54: 959.
22. Siegling A, Lehmann M, Riedel H, et al. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
23. Binder J, Hancock WW, Wasowska B, et al. Donor specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells. Transplant Proc 1995; 27: 114.
24. + T cells. Transplantation 1992; 54: 483.
25. Qin SX, Wise M, Cobbold SP, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
26. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990; 20: 2747.
27. Burkhardt K, Charlton B, Mandel TE. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine. Transplantation 1989; 47: 771.
28. Darby CR, Bushell A, Morris PJ, Wood KJ. Nondepleting anti-CD4 antibodies in transplantation: evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 1994; 57: 1419.
29. Stumbles P, Mason D. Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995; 182: 5.
30. Zurawski G, deVries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15: 19.
31. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo (erratum: Eur J Immunol 1994; 24: 785) Eur J Immunol 1993; 23: 2223.
32. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
33. Gallimore PH. Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA in nine lines of transformed rat cells using specific fragments of the viral genome. J Mol Biol 1974; 89: 49.
34. Bellgrau D. Induction of cytotoxic T cell precursors in vivo. Role of T helper cells. J Exp Med 1983; 157: 1505.
35. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
36. Gianello PR, Blancho G, Fishbein JF, et al. Mechanism of cyclosporin-induced tolerance to primarily vascularized allografts in miniature swine: effect of administration of exogenous IL-2. J Immunol 1994; 153: 4788.
37. Sayegh MH, Perico N, Gallon L, et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125.
38. Chen H, Luo H, Daloze P, Xu D, Wu J. Rapamycin-induced long-term allograft survival depends on persistence of alloantigen. J Immunol 1994; 152: 3107.
39. Nisco SJ, Hissink RJ, Vriens PW, Hoyt EG, Reitz BA, Clayberger C. In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine: Radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cells. Transplantation 1995; 59: 1444.
40. Takeuchi Y, Horiuchi T, Hamamura K, Sugimoto T, Yagita H, Okumura K. Role of CD4 molecule in intrathymic T-cell development. Immunology 1991; 74: 183.
41. Lindsey JW, Hodgkinson S, Mehta R, Mitchell D, Enzmann D, Steinman L. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann Neurol 1994; 36: 183.
42. Saitovitch D, Bushell AR, Morris PJ, Wood KJ. Induction of transplantation tolerance using a nondepleting anti-CD4 mAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. Transplant Proc 1995; 27: 117.
43. Choy EH, Panayi GS, Kingsley GH. Therapeutic monoclonal antibodies. Br J Rheumatol 1995; 34: 707.
44. Cosimi AB, Delmonico FL, Wright JK, et al. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
45. Morel P, Vincent C, Wijdenes J, Revillard JP. Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes. Mol Immunol 1993; 30: 649.
46. Waldmann H. Manipulation of T-cell responses with monoclonal antibodies. Annu Rev Immunol 1989; 7: 407.
47. Bank I, Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J Exp Med 1985; 162: 1294.
48. Choy EH, Adjaye J, Forrest L, Kingsley GH, Panayi GS. Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes. Eur J Immunol 1993; 23: 2676.
49. Banda NK, Bernier J, Kurahara DK et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176: 1099.
50. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 crosslinked PBMCs from normal individuals. Blood 1993; 82: 3392.
51. Wang ZQ, Dudhane A, Orlikowsky T, et al. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur J Immunol 1994; 24: 1549.
52. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 1993; 55: 1112.
53. Kupiec-Weglinski JW, Wasowska B, Papp I, et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053.
54. Pfeiffer C, Murray J, Madri J, Bottomly K. Selective activation of Th1- and Th2-like cells in vivo - response to human collagen IV. Immunol Rev 1991; 123: 65.
55. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181: 1569.
56. Hauss P, Selz F, Cavazzana-Calvo M, Fischer A. Characteristics of antigen independent and antigen-dependent interaction of dendritic cells with CD4+ T cells. Eur J Immunol 1995; 25: 2285.
57. Mazerolles F, Barbat C, Meloche S, et al. LFA-1-mediated antigen-independent T cell adhesion is regulated by CD4 and p561ck tyrosine kinase. J Immunol 1994; 152: 5670.
58. + T cells differing in CD45R expression. J Immunol 1992; 149: 2300.
59. Qin SX, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
60. Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491.
61. Karpus WJ, Peterson JD, Miller SD. Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. Int Immunol 1994; 6: 721.
62. Melamed D, Friedman A. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Eur J Immunol 1994; 24: 1974.
63. Facchinetti A, Panozzo M, Pertile P, Tessarollo L, Biasi G. In vivo and in vitro death of mature T cells induced by separate signals to CD4 and αβ TCR. Immunobiology 1992; 185: 380.
64. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994; 24: 2383.